Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARACHUTE-HF
NCT04023227Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2019
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), Chagas disease, sponsored by Novartis. Started Dec 2019; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)Chagas disease
Beyond the preview
Go deeper on NCT04023227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04023227.